SCHEMBL5717037

SCHEMBL5717037

COC(=O)C1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 3/20 0.57
HCRTR2 O43614 3/20 0.57
KCNQ1 P51787 1/20 0.57
BRD4 O60885 3/20 0.56
CASP3 P42574 1/20 0.55
ALDH1A1 P00352 3/20 0.55
MMP1 P03956 1/20 0.55
MMP3 P08254 1/20 0.55
MMP7 P09237 1/20 0.55
MMP13 P45452 1/20 0.55
HSD11B1 P28845 1/20 0.53
KMT2A Q03164 2/20 0.53
BRD2 P25440 2/20 0.53
MEN1 O00255 1/20 0.53
HTT P42858 1/20 0.51
EPHX2 P34913 1/20 0.50
GAA P10253 1/20 0.49
FKBP1A P62942 2/20 0.48
LMNA P02545 1/20 0.48
TSHR P16473 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20291072 0.89 BRD4 (0.73) HCRTR1HCRTR2BRD4ALDH1A1KMT2A
SCHEMBL5717004 0.88 CASP3 (0.59) HCRTR1HCRTR2KCNQ1BRD4CASP3
SCHEMBL5717102 0.87 ALDH1A1 (0.64) HCRTR1HCRTR2BRD4ALDH1A1KMT2A
SCHEMBL5717227 0.87 ALDH1A1 (0.64) HCRTR1HCRTR2BRD4ALDH1A1KMT2A
SCHEMBL5717122 0.87 BRD4 (0.51) HCRTR1HCRTR2KCNQ1BRD4ALDH1A1
SCHEMBL5717100 0.87 ALDH1A1 (0.64) HCRTR1HCRTR2BRD4ALDH1A1KMT2A
SCHEMBL23630452 0.85 ALDH1A1 (0.55) HCRTR1HCRTR2BRD4ALDH1A1MMP1
SCHEMBL5716989 0.85 ALDH1A1 (0.66) HCRTR1HCRTR2KCNQ1BRD4ALDH1A1
SCHEMBL5716988 0.85 ALDH1A1 (0.66) HCRTR1HCRTR2KCNQ1BRD4ALDH1A1
SCHEMBL5717022 0.85 ALDH1A1 (0.66) HCRTR1HCRTR2KCNQ1BRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed